Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: The 4D study

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 659-662

  Hoffmann, Michael M ^a   März, Winfried ^b,c   Genser, Bernd ^b,d   Drechsler, Christiane ^e   Wanner, Christoph ^e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c SYNLAB ACADEMY   (Germany)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Coronary artery disease; Hemodialysis; KIF6; Pharmacogenetic; Statin treatment; Type 2 diabetes mellitus

Indexed keywords

ATORVASTATIN; DNA; KINESIN; KINESIN LIKE PROTEIN 6; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HEART DEATH; HEART INFARCTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

AGED; ANALYSIS OF VARIANCE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DOUBLE-BLIND METHOD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KINESIN; LOGISTIC MODELS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PYRROLES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 82955247864     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.07.126     Document Type: Article

References (15)

1. Lloyd-Jones D., Adams R.J., Brown T.M., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
2. Baigent C., Keech A., Kearney P.M., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278.
3. Prichard S.S. Impact of dyslipidemia in end-stage renal disease. J Am Soc Nephrol 2003, 14:S315-S320.
4. Wanner C., Krane V., Marz W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005, 353:238-248.
5. Iakoubova O.A., Tong C.H., Rowland C.M., et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. J Am Coll Cardiol 2008, 51:435-443.
6. Iakoubova O.A., Sabatine M.S., Rowland C.M., et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. J Am Coll Cardiol 2008, 51:449-455.
7. Hopewell J.C., Parish S., Clarke R., et al. No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the Heart Protection Study. J Am Coll Cardiol 2011, 57:2000-2007.
8. Ridker P.M., Macfadyen J.G., Glynn R.J., Chasman D.I. KIF6 polymorphism and the efficacy of rosuvastatin in primary prevention. Circ Cardiovasc Genet 2011, 4:312-317.
9. Assimes T.L., Holm H., Kathiresan S., et al. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol 2010, 56:1552-1563.
10. Bare L.A., Morrison A.C., Rowland C.M., et al. Five common gene variants identify elevated genetic risk for coronary heart disease. Genet Med 2007, 9:682-689.
11. Shiffman D., O'Meara E.S., Bare L.A., et al. Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 2008, 28:173-179.
12. Shiffman D., Chasman D.I., Zee R.Y., et al. A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study. J Am Coll Cardiol 2008, 51:444-448.
13. Li Y., Sabatine M.S., Tong C.H., et al. Genetic variants in the KIF6 region and coronary event reduction from statin therapy. Hum Genet 2011, 129:17-23.
14. Stewart A.F., Dandona S., Chen L., et al. Kinesin family member 6 variant Trp719Arg does not associate with angiographically defined coronary artery disease in the Ottawa Heart Genomics Study. J Am Coll Cardiol 2009, 53:1471-1472.
15. Fellstrom B.C., Jardine A.G., Schmieder R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009, 360:1395-1407.